Orapred and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Orapred (prednisolone sodium phosphate), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Dysport, and have Urticaria.

The phase IV clinical study analyzes which people have Weakness when taking Orapred. It is created by eHealthMe based on reports of 393 people who have side effects when taking Orapred from the FDA, and is updated regularly.

What is Orapred?

Orapred has active ingredients of prednisolone sodium phosphate. It is often used in croup. eHealthMe is studying from 428 Orapred users. Check the latest studies of Orapred.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,618 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 27, 2026

393 people reported to have side effects when taking Orapred.
Among them, 15 people (3.82%) have Weakness.

Among these 15 people:

How long have people been on Orapred when they have Weakness? *

What is the gender of people who have Weakness when taking Orapred? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Weakness when taking Orapred? *

What are other drugs people take besides Orapred? *

What are other side effects people have besides Weakness? *

Respiratory Distress (difficulty in breathing): 6 people, 40.00%
Pain: 6 people, 40.00%
The Flu (the flu is caused by an influenza virus): 6 people, 40.00%
Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 33.33%
Cough: 5 people, 33.33%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 33.33%
Neuromyopathy (disease of both muscles and nerves): 4 people, 26.67%
Joint Instability (a condition in which the joints aren't sufficiently supported): 4 people, 26.67%
Nausea And Vomiting: 4 people, 26.67%
Respiratory Syncytial Virus Bronchiolitis (a lower respiratory tract infection due to virus): 4 people, 26.67%

What are the existing conditions these people have? *

Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 33.33%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 26.67%
Iron Deficiency: 4 people, 26.67%
Spinal Muscular Atrophy (wasting of spinal muscles): 4 people, 26.67%
Pneumonia: 4 people, 26.67%
Otitis Media (inflammation of the middle ear): 4 people, 26.67%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 26.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 26.67%
Dyspnea (difficult or laboured breathing): 4 people, 26.67%
Excessive Granulation Tissue (excessive collagen-rich tissue which forms at the site of an injury): 4 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take Orapred and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Orapred:

Orapred (428 reports)

Weakness treatments and more:

Weakness (586,877 reports)

Browse all side effects of Orapred:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,638 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,618 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednisolone sodium phosphate (the active ingredients of Orapred) and Orapred (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.